Selection of an adjuvant for vaccination with the malaria antigen, MSA-2
- 22 June 1997
- Vol. 15 (9) , 1017-1023
- https://doi.org/10.1016/s0264-410x(96)00289-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Safety, Immunogenicity, and Pilot Efficacy of Plasmodium falciparum Sporozoite and Asexual Blood-Stage Combination Vaccine in Swiss AdultsThe American Journal of Tropical Medicine and Hygiene, 1995
- Protective Immunity Induced in Squirrel Monkeys with Recombinant Apical Membrane Antigen-1 of Plasmodium fragileThe American Journal of Tropical Medicine and Hygiene, 1994
- Proteins on the surface of the malaria parasite and cell invasionParasitology, 1994
- Merozoite surface antigen-I of plasmodiumParasitology Today, 1993
- Preparation of clinical grade proteins produced by recombinant DNA technologiesJournal of Immunological Methods, 1991
- Liposomes as carriers of antigens and adjuvantsJournal of Immunological Methods, 1991
- Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparumMolecular and Biochemical Parasitology, 1990
- Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunityVaccine, 1987
- Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparumNature, 1986
- FOLLOW-UP STUDY ON ARMY PERSONNEL WHO RECEIVED ADJUVANT INFLUENZA VIRUS VACCINE 1951???1953The Lancet Healthy Longevity, 1964